Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Tyrosine Kinase Inhibitors
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
4
8
12
16
20
24
28
32
36
40
tofacitinib
/ Generic mfg.
Tavalisse
(fostamatinib) / Rigel
BIAsp 30
(biphasic insulin aspart 30/70 biosimilar) / Novo Nordisk
DegludecPlus
(insulin degludec/insulin aspart) / Novo Nordisk
insulin peglispro
(LY2605541) / Eli Lilly
Afrezza
(recombinant human insulin inhalation) / MannKind
Olumiant
(baricitinib) / Eli Lilly
Basaglar
(insulin glargine biosimilar) / Boehringer Ingelheim, Eli Lilly
Avastin
(bevacizumab) / Roche
Generex Oral-lyn
(insulin buccal spray) / Generex, Dong Sung Pharma, Shreya Life Sci
Humalog ILPS
(insulin lispro protamine suspension) / Eli Lilly
Linjeta
(prandial insulin) / Ipsen
Wosulin 30/70
(recombinant human insulin biosimilar 30% + isophane insulin biosimilar 70%) / Wockhardt
Wosulin R
(recombinant human insulin biosimilar) / Wockhardt
